| 英文别名 |
N2-Acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-L-tyrosine;AK608090;(3S)-3-[[(2S)-2-acetamido-6-aminohexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid;Peptigravity;Peptigravity;Peptigravity;(2S,5S,8S,11S)-11-(4-aminobutyl)-8-(carboxymethyl)-2-(4-hydroxybenzyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanoic acid;(2S,5S,8S,11S)-11-(4-aminobutyl)-8-(carboxymethyl)-2-(4-hydroxybenzyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanoic acid;(2S,5S,8S,11S)-11-(4-aminobutyl)-8-(carboxymethyl)-2-(4-hydroxybenzyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecanoic acid;Ac-lys-asp-val-tyr;Ac-lys-asp-val-tyr;Ac-lys-asp-val-tyr;757942-88-4;757942-88-4;757942-88-4;L-TYROSINE, N2-ACETYL-L-LYSYL-L-.ALPHA.-ASPARTYL-L-VALYL-;L-TYROSINE, N2-ACETYL-L-LYSYL-L-.ALPHA.-ASPARTYL-L-VALYL-;L-TYROSINE, N2-ACETYL-L-LYSYL-L-.ALPHA.-ASPARTYL-L-VALYL-;SCHEMBL24739787;SCHEMBL24739787;SCHEMBL24739787;Acetyl tetrapeptide-2 [INCI];Acetyl tetrapeptide-2 [INCI];Acetyl tetrapeptide-2 [INCI];CS-0138091;CS-0138091;CS-0138091;Q27283376;Q27283376;Q27283376;C76421;C76421;C76421;Acetyl tetrapeptide-2;Acetyl tetrapeptide-2;Acetyl tetrapeptide-2;C26H39N5O9;C26H39N5O9;C26H39N5O9;MFCD30573923;MFCD30573923;MFCD30573923;DA-75919;DA-75919;DA-75919;N2-Acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-L-tyrosine (Ac-Lys-Asp-Val-Tyr-OH);N2-Acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-L-tyrosine (Ac-Lys-Asp-Val-Tyr-OH);N2-Acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-L-tyrosine (Ac-Lys-Asp-Val-Tyr-OH);M24S4WZS8J;M24S4WZS8J;M24S4WZS8J;UNII-M24S4WZS8J;UNII-M24S4WZS8J;UNII-M24S4WZS8J;(2S,5S,8S,11S)-11-(4-Aminobutyl)-8-(carboxymethyl)-2-(4-hydroxybenzyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic acid;(2S,5S,8S,11S)-11-(4-Aminobutyl)-8-(carboxymethyl)-2-(4-hydroxybenzyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic acid;(2S,5S,8S,11S)-11-(4-Aminobutyl)-8-(carboxymethyl)-2-(4-hydroxybenzyl)-5-isopropyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazatetradecan-1-oic acid;AKOS030573454;AKOS030573454;Thymulen 4;AKOS030573454;Thymulen 4;HY-P2663;Thymulen 4;HY-P2663;HY-P2663;(3S)-3-[(2S)-6-amino-2-acetamidohexanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propanoic acid;(3S)-3-[(2S)-6-amino-2-acetamidohexanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propanoic acid;DS-19818;(3S)-3-[(2S)-6-amino-2-acetamidohexanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]carbamoyl}-2-methylpropyl]carbamoyl}propanoic acid;DS-19818;L-Tyrosine, N2-acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-;DS-19818;L-Tyrosine, N2-acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-;L-Tyrosine, N2-acetyl-L-lysyl-L-alpha-aspartyl-L-valyl- |